SIRT2 reduces actin polymerization and cell migration through deacetylation and degradation of HSP90

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Biology

Background:

• Sirtuin 2 (SIRT2), a class III histone deacetylase, is recognized as a tumor suppressor involved in metabolism and proliferation.
• The precise role of SIRT2 in cancer cell migration, particularly concerning cytoskeletal dynamics, remains incompletely understood.

Purpose of the Study:

• To elucidate the function of SIRT2 in regulating cancer cell motility.
• To investigate the molecular mechanisms by which SIRT2 influences cytoskeletal rearrangement and cell migration.

Main Methods:

• Investigated the effect of SIRT2 on actin polymerization and cell motility.
• Examined the interaction between SIRT2 and heat shock protein 90 (HSP90).
• Analyzed SIRT2's regulation of HSP90 acetylation, ubiquitination, and proteasomal degradation, and its impact on the LIM kinase (LIMK) 1/cofilin pathway.

Main Results:

• SIRT2 was found to inhibit cancer cell motility by suppressing actin polymerization.
• SIRT2 directly interacts with HSP90, modulating its acetylation and ubiquitination.
• SIRT2 regulates actin dynamics via HSP90 destabilization, leading to repression of the LIMK1/cofilin pathway.
• The deacetylase activity of SIRT2 is crucial for controlling actin polymerization and facilitating HSP90 degradation.

Conclusions:

• SIRT2 acts as an inhibitor of cancer cell migration by disrupting actin dynamics.
• SIRT2 modulates HSP90 stability and activity, thereby influencing the LIMK1/cofilin pathway.
• These findings highlight a novel mechanism for SIRT2 in regulating cell motility and suggest its potential as a therapeutic target in cancer.